SUBSTANTIAL DECREASE OF PLASMA APOA-I IN CHOLESTEROL-FED RABBITS - DEMONSTRATION OF A PROTECTIVE EFFECT OF APOA-I AGAINST ATHEROSCLEROSIS INVIVO

被引：0

作者：

MAO, SJT ^{[1
]}

DINH, DM ^{[1
]}

BALE, LK ^{[1
]}

CHANG, JY ^{[1
]}

MACIEJKO, JJ ^{[1
]}

机构：

[1] MAYO CLIN & MAYO FDN,ROCHESTER,MN 55901

来源：

FEDERATION PROCEEDINGS | 1983年 / 42卷 / 07期

关键词：

D O I：

暂无

中图分类号：

Q [生物科学];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

引用

页码：1818 / 1818

页数：1

共 50 条

[31] ENTHALPY OF ASSOCIATION OF APOLIPOPROTEIN A-I (APOA-I) WITH LECITHIN-CHOLESTEROL MIXTURES [J].

CHATURVEDI, BK ;

MASSEY, JB ;

GOTTO, AM ;

POWNALL, HJ .

FEDERATION PROCEEDINGS, 1982, 41 (04) :1021-1021

[32] Expression of serum amyloid A protein in the absence of the acute phase response does not reduce HDL cholesterol or apoA-I levels in human apoA-I transgenic mice [J].

Hosoai, H ;

Webb, NR ;

Glick, JM ;

Tietge, UJF ;

Purdom, MS ;

de Beer, FC ;

Rader, DJ .

JOURNAL OF LIPID RESEARCH, 1999, 40 (04) :648-653

[33] Apolipoprotein A-I (ApoA-I) Mimetic Peptide P2a by Restoring Cholesterol Esterification Unmasks ApoA-I Anti-Inflammatory Endogenous Activity In Vivo [J].

Bucci, Mariarosaria ;

Cigliano, Luisa ;

Vellecco, Valentina ;

D'Andrea, Luca Domenico ;

Ziaco, Barbara ;

Rossi, Antonietta ;

Sautebin, Lidia ;

Carlucci, Alessandro ;

Abrescia, Paolo ;

Pedone, Carlo ;

Ianaro, Angela ;

Cirino, Giuseppe .

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2012, 340 (03) :716-722

[34] The ApoA-I peptide mimetic 5A protects against atherosclerosis in apoE deficient mice [J].

Amar, Marcelo J. ;

Basso, Federica ;

Demosky, Steve ;

Stonick, John ;

Remaley, Alan T. .

CIRCULATION, 2006, 114 (18) :23-23

[35] LCAT cholesterol esterification is associated with the increase of ApoE/ApoA-I ratio during atherosclerosis progression in rabbit [J].

Carlucci, Alessandro ;

Cigliano, Luisa ;

Maresca, Bernardetta ;

Spagnuolo, Maria Stefania ;

Di Salvo, Giovanni ;

Calabro, Raffaele ;

Abrescia, Paolo .

JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY, 2012, 68 (04) :541-553

[36] Human secretory phospholipase A2 (sPLA2) mediates decreased plasma levels of HDL-cholesterol and ApoA-I in response to inflammation in human ApoA-I transgenic mice [J].

Tietge, UJ ;

Maugeais, C ;

Lund-Katz, S ;

Grass, D ;

De Beer, FC ;

Rader, DJ .

CIRCULATION, 2001, 104 (17) :269-269

[37] Nonenzymatically glycated lipoprotein ApoA-I in plasma of diabetic and nephropathic patients [J].

Lapolla, Annunziata ;

Brioschi, Maura ;

Banfi, Cristina ;

Tremoli, Elena ;

Cosma, Chura ;

Bonfante, Luciana ;

Cristoni, Simone ;

Seraglia, Roberta ;

Traldi, Pietro .

MAILLARD REACTION: RECENT ADVANCES IN FOOD AND BIOMEDICAL SCIENCES, 2008, 1126 :295-299

[38] Regression of aortic valve stenosis by ApoA-I mimetic peptide infusions in rabbits [J].

Busseuil, D. ;

Shi, Y. ;

Mecteau, M. ;

Brand, G. ;

Kernaleguen, A-E ;

Thorin, E. ;

Latour, J-G ;

Rheaume, E. ;

Tardif, J-C .

BRITISH JOURNAL OF PHARMACOLOGY, 2008, 154 (04) :765-773

[39] ApoA-I Mimetic Peptides Prevent Atherosclerosis Development in a Mouse Model of Diabetes [J].

Morgantini, Cecilia ;

Grijalva, Victor ;

Navab, Mohamad ;

Fogelman, Alan M. ;

Reddy, Srinivasa T. .

DIABETES, 2010, 59 :A26-A26

[40] LCAT cholesterol esterification is associated with the increase of ApoE/ApoA-I ratio during atherosclerosis progression in rabbit [J].

Alessandro Carlucci ;

Luisa Cigliano ;

Bernardetta Maresca ;

Maria Stefania Spagnuolo ;

Giovanni Di Salvo ;

Raffaele Calabrò ;

Paolo Abrescia .

Journal of Physiology and Biochemistry, 2012, 68 :541-553

← 1 2 3 4 5 →